Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Fair enough. I can only share what I have discover

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153798
(Total Views: 704)
Posted On: 07/10/2020 2:03:21 PM
Posted By: StinkyPennies
Re: ClosetInvestor #42177
Fair enough. I can only share what I have discovered on my own by making inquiries on this matter and many others. If you have doubts, you could even inquire with the NEJM yourself as to their policies. I also think CDiddy has great avenues to get accurate info and will support anything he finds solid.

To be clear - you may have misunderstood my OP - the NEJM (IMO) shut down the entire process when a CYDY officer said, in a public forum, that the "NEJM would be publishing BP's paper next week (paraphrased)." It was not a rejection of the content. It was NP's public rant which disqualified the process based on NEJM guidelines. AGAIN - this had nothing to do with the validity of BP's research. It has to do with NP violating rules of submission. An unforced error, if you will.

In the future, do your own digging and find things out for yourself. You shouldn't trust me or any other anonymous screen name on a message board!

Quote:
I find your claim hard to believe, especially given your posting history and alias. I’m unsure how NP mentioning data before submission has anything to do with nullifying the peer review or publication process. Many COVID related articles in the NEJM were discussed before NEJM published them. Additionally, the ENTIRE article is published online, for the world to review and peers to review, prior to submission to a journal. So again, NP mentioning the findings on a paid interview doesn’t seem to meet criteria for rejection.

I’ll await feedback from CDiddy or another legitimate investor to confirm whether your statement is true as anything is possible at this point.

Read More: https://investorshangout.com/post/view?id=582...z6Roeh3Ew9



(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us